Happy to announce our #IBD research, in which we use faecal calprotectin over time to characterise Crohn's disease heterogeneity, is now available as an article in press with @AGA_CGH! (Open access and proofed versions to follow at a later date) https://t.co/iHSd2aO6sC

🚀 Excited to introduce the ChatIBD Beta: an AI platform to support IBD clinicians in accessing IBD guidelines • Global access/multi-lingual • Guideline-grounded answers • Curated dosing database Link and technical deep dive below 👇

🙏 UK colleagues! 👩‍💻🧑‍💻please Complete the survey! @CrohnsColitisUK @IBDUKTEAM @Y_ECCO_IBD @IBDNathan 🙏 for sharing @ShahidaDin1 @BritSocGastro @ibduk

Interviews with @charlie_lees and I were broadcast on @STVNews today. We discussed our work showing whilst advanced therapy use in ulcerative colitis has been rising in NHS Lothian, colectomies have been falling.

@Bealoquebea, @AlexElford3 @charlie_lees @PlevrisN @UoE_CGEM @EdinUni_IGC

Nice to see our propensity-weighted comparison of first-line vedolizumab and tofacitinib is now published. We found that the persistence & tolerability of vedolizumab were superior to tofacitinib despite comarable rates of clinical and biomarker remission

Just in case you didn’t realise we’re a Scottish research group

This photo is simply unbeatable I’ve missed this team more than words can say. 💙 @charlie_lees @IBDNathan @PlevrisN Sat hiking with the highland cows

4 chances to shape the future of IBD care in Edinburgh Our translational research team at the University of Edinburgh is building an AI‑driven clinical decision‑support platform that will change how inflammatory bowel disease is predicted and managed worldwide. We’re adding:

We're hiring a data science post doc! Work with @charlie_lees and @CataVallejosM (and me!) in Edinburgh. This is a great data science and clinical collaboration leveraging longitudinal IBD biomarkers and EHR data, integrating our findings into a clinical decision support tool

Exciting Opportunity: Data Scientist - IBD Research Team We're expanding our world-class research team @EdinUni_IGC What we're building: An AI-driven dynamic clinical decision support tool that will transform how we predict and manage outcomes for IBD patients globally. Who

@IBDNathan has written a brave and powerful blog for World IBD Day He discusses what it is like to live with IBD and have a career working in IBD data science Grab a cup and have a read (link below) 👇

Also get more context than just a stoma bag 😅

For #WorldIBDDay, read my blog post to learn my story of going from IBD patient to IBD researcher.

Very thankful and proud to get a poster poster of distinction at #DDW2025 for my UC advanced therapy prescriptions and coelctomy data over 20 years in Lothian. Thanks to all my co authors, especially @IBDNathan for your statistical brilliance and @charlie_lees for your mentoring

Great poster from @IBDNathan . It's been a pleasure to be a part of this project...Future of IBD monitoring #DDW2025

At #DDW2025? Come find me at poster 1935 in today’s poster session to hear about the @charlie_lees’ group’s work identifying distinct longitudinal FCAL and CRP patterns across over 12,000 Scots and Danes and their relationship with AT prescribing. A collaboration w/ @PREDICTIBD

@marie_vibeke @PlevrisN @monterrubiok @clara_ramosb @AlexElford3 @Bealoquebea @alehins @Gastro_GRJ @CataVallejosM @DrTineJess @charlie_lees @UoE_CGEM @EdinUni_IGC

It was a pleasure to present our collaboration with @PREDICTIBD at #ECCO2025 last week. We demonstrate subgroups of IBD patients can be characterised by distinct FC and CRP profiles, validated independently in 🇩🇰. The preprint is available here: https://t.co/1I8wedE8bl

So proud of @LauranneDerikx and @alehins for these prizes

Very proud of the team at ECCO Two plenary talks - both won prizes - great posters and brilliant energy throughout. Many great things to come … importantly, everything we do is to advance care and improve lives for patients with IBD. @IBDNathan @Bealoquebea @LauranneDerikx